ICH guidelines are developed through a collaborative process involving regulatory authorities and pharmaceutical industry experts from Europe, Japan, and the United States. This process ensures that the guidelines reflect the latest scientific knowledge and regulatory requirements. The guidelines are periodically reviewed and updated to incorporate new scientific insights and technological advancements.
